Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study
Authors:
- Pavlos MyrianthefsPMPavlos Myrianthefs
- Sophia L. MarkantonisSMSophia L. Markantonis
- Penelope EvaggelopoulouPEPenelope Evaggelopoulou
- Stratos DespotelisSDStratos Despotelis
- Effimia EvodiaEEEffimia Evodia
- Dimitris PanidisDPDimitris Panidis
- George BaltopoulosGBGeorge Baltopoulos
- 1 May 2010
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (5) , 468-472
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Therapeutic drug monitoring for triazolesCurrent Opinion in Infectious Diseases, 2008
- Is Candida really a threat in the ICU?Current Opinion in Critical Care, 2008
- Impact of Intravenous Administration of Voriconazole in Critically Ill Patients with Impaired Renal FunctionJournal of Chemotherapy, 2008
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety OutcomesClinical Infectious Diseases, 2008
- Patients at High Risk of Invasive Fungal InfectionsDrugs, 2008
- Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired SubjectsClinical Drug Investigation, 2008
- Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapyBMC Clinical Pharmacology, 2006
- Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test AbnormalitiesThe Journal of Clinical Pharmacology, 2006
- Adverse Reactions to VoriconazoleClinical Infectious Diseases, 2004
- A rapid HPLC assay for voriconazole in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 1998